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Abstract
Background: Vitamin C (vit C) is an essential dietary nutrient, which is a potent antioxidant, a free radical scavenger
and functions as a cofactor in many enzymatic reactions. Vit C is also considered to enhance the immune effector
function of macrophages, which are regarded to be the first line of defence in response to any pathogen. The THP-
1 cell line is widely used for studying macrophage functions and for analyzing host cell-pathogen interactions.
Results: We performed a genome-wide temporal gene expression and functional enrichment analysis of THP-1
cells treated with 100 μM of vit C, a physiologically relevant concentration of the vitamin. Modulatory effects of
vitamin C on THP-1 cells were revealed by differential expression of genes starting from 8 h onwards. The number
of differentially expressed genes peaked at the earliest time-point i.e. 8 h followed by temporal decline till 96 h.
Further, functional enrichment analysis based on statistically stringent criteria revealed a gamut of functional
responses, namely, ‘Regulation of gene expression’, ‘Signal transduction’, ‘Cell cycle’, ‘Immune system process’,
‘cAMP metabolic process’, ‘Cholesterol transport’ and ‘Ion homeostasis’. A comparative analysis of vit C-mediated
modulation of gene expression data in THP-1cells and human skin fibroblasts disclosed an overlap in certain
functional processes such as ‘Regulation of transcription’, ‘Cell cycle’ and ‘Extracellular matrix organization’, and
THP-1 specific responses, namely, ‘Regulation of gene expression’ and ‘Ion homeostasis’. It was noteworthy that vit
C modulated the ‘Immune system’ process throughout the time-course.
Conclusions: This study reveals the genome-wide effects of physiological levels of vit C on THP-1 gene expression.
The multitude of effects impacted by vit C in macrophages highlights its role in maintaining homeostasis of several
cellular functions. This study provides a rational basis for the use of the Vitamin C- THP-1 cell model, to study
biochemical and cellular responses to stresses, including infection with M. tuberculosis and other intracellular
pathogens.
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Background
Human leukocytes and cultured cells of leukocyte origin
can accumulate vitamin C (vit C) to millimolar concen-
trations, which is significantly above that in circulating
blood where it is estimated to be in the range of about
50-100 μM, and of this at least 95% is in the reduced
form [1–4]. Vit C is accumulated in mammalian cells by
two types of transporters, namely, sodium-ascorbate co-
transporters (SVCTs) for active transport of the reduced
form and hexose transporters (GLUTs) for taking up the
oxidized form, dehydroascorbate (DHA) [5]. Activated
THP-1 cells rapidly accumulate vit C to millimolar
concentrations, similar to activated RAW264.7 murine
macrophages [6, 7]. Ascorbate is a cytosolic antioxidant
and free radical scavenger that operates in concert with
lipid-soluble membrane antioxidants, such asα-tocopherol
or carotene, and may increase the ability of cells to cope
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with reactive oxygen metabolites generated by their ac-
tivated phagocytic apparatus [8, 9]. Vit C also functions
as a cofactor for enzymes involved in the biosynthesis
of collagen [10, 11] and norepinephrine [12], and in the
amidation of hormones [13]. Several studies have described
that adequate circulating levels of vit C are consistent with
a decreased risk of varied disease pathologies, such as
stroke [14] or cardiovascular disease [15]. In this context,
vit C supplementation has been reported to provide symp-
tomatic relief and to enhance the expression of specific
immune response markers [16]. It is noteworthy that most
of the studies addressing the effects of vit C at optimum
levels (70 μmol/l) on human health considered its supple-
mentation together with other nutrients (usually zinc or
within a multivitamin–multimineral formula), whilst a real
understanding of its mechanism of action would possibly
require its supplementation as a single component [17].
Mycobacteria-macrophage interactions have been char-
acterized in primary as well as in vitro-differentiated cells
to mimic the events that are considered to occur in vivo,
namely, the entry and intracellular residence of Mycobac-
terium tuberculosis (Mtb) within alveolar macrophages
[18–20]. Macrophage-like cell lines of human origin are
considered as good models for in vitro-differentiated
monocyte-derived macrophages [21]; moreover, they have
the advantages of no donor variability of macrophage
function, large numbers of cells can be grown reprodu-
cibly, cells can be studied at different stages (resting
versus activated) and the cells closely model alveolar
macrophages for processing of intracellular pathogens,
for example Mtb-induced apoptosis [22]. Importantly,
the human acute monocytic leukemia cell line, THP-1,
develops macrophage functions following the addition
of stimulators such as Phorbol myristate acetate (PMA)
[23]. These differentiated THP-1 cells showed remark-
able phenotypic changes e.g., increased phagocytic ac-
tivity and HLA-DR expression, increased complement
receptor, FcγRI and FcγRII expression [24], CD11b, and
CD14 [24, 25], indicating their similarity but not iden-
tity with mature human macrophages. THP-1 cells were
found to be a suitable ex vivo infection model for
studying Mtb-host interactions and anti-mycobacterials’
action on intracellular bacteria and yielded results compar-
able to that obtained using monocyte-derived macrophages
(MDMs) [21].
We have reported earlier that tubercle bacilli treated
with vit C develop an isoniazid-tolerant phenotype that
is considered to be an indicator of bacterial dormancy.
The vit C-induced drug tolerant response occurred in
vitro as well as in infected THP-1 cells [26]. In view of
the ability of vit C to induce a ‘dormant’ phenotype in
Mtb, a temporal transcriptome profiling study of base-
line gene expression to assess the response of THP-1
cells to vit C was undertaken. It was expected that such
an analysis would pave the way for utilizing the vit C-
based THP-1 infection model to study interactions of
host cells with ‘dormant’ Mtb.
Methods
Cell culture conditions
THP-1 cells were grown to confluency in complete RPMI
1640 (Sigma-Aldrich®) medium (c-RPMI) supplemented
with 2 mM glutamine, HEPES and sodium bicarbonate
with 10% fetal bovine serum (HyClone™) and 1×
Penicillin-Streptomycin solution (Sigma-Aldrich®) in 5%
CO2, at 37 °C. Cell viability was checked by Trypan
Blue exclusion and 99% viable cultures were used for
gene expression studies.
Gene expression analysis
Approximately, 8 × 106 THP-1 cells were seeded per T-
75 cm2 flask/20 ml c-RPMI in triplicate. Following differ-
entiation with 30 nM phorbol myristate acetate (PMA) for
16–18 h, fresh c-RPMI was added and the cells were
rested for 2–3 h. Subsequently, vit C (100 μM, Sigma-
Aldrich®) was added to the treated flasks and not in the
untreated (UT, control) flasks. At specified time-points (8,
24, 48 and 96 h) cells were harvested (vit C-treated and
control flasks), the cell pellet was re-suspended in 1 ml
TRI reagent (Molecular Research Center, USA) and stored
at -80 °C for the isolation of RNA.
RNA isolation and microarray analysis
Briefly, 1/10th volume of bromochloropropane (Molecular
Research Center, USA) was added to thawed THP-1 ly-
sates, vigorously shaken for 10 s and incubated for 10 min
at room temperature. The samples were centrifuged at
12,000 rpm for 15 min at 4 °C. Precipitation was carried
out in the presence of 1/100th volume of polyacryl carrier
and isopropanol (0.6 volumes, for 30 min), centrifuged
(12,000 rpm, 4 °C for 15 min), washed with 75% ethanol
and then air-dried. Total RNA was dissolved in 100 μl of
DEPC-treated water. Ten μg of total RNA was subjected
to microarray analysis.
A total of 24 RNA samples (3 biological replicates per
condition) were analyzed for RNA integrity and 19 sam-
ples, whose RIN (RNA integrity number) was ≥7, were
processed for microarray analysis (Fig. 1a). The samples
were labeled using Agilent Quick Amp Kit. Briefly,
500 ng of total RNA was reverse transcribed using oli-
godT primer tagged to T7 promoter sequence. cDNA
thus obtained was converted to double stranded cDNA
and to cRNA in the in-vitro transcription step using T7
RNA polymerase enzyme. Cy3 dye was added into the
reaction mix. cRNA was cleaned up using Qiagen
RNeasy columns. Samples that passed the QC for spe-
cific activity were taken for hybridization. Labeled cRNA
(600 ng) was hybridized to Human Whole Genome 8 ×
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60 K Array (Agilent Technologies AMADID: 027114)
using the Agilent Gene Expression Hybridization kit at
65 °C for 16 h. The hybridized slides were washed and
scanned on G2505C scanner. Data extraction from Im-
ages was done using Feature Extraction software Version
10.7 of Agilent Technologies.
Microarray data processing and analysis
A plan of the microarray analysis is shown in Fig. 1a.
Raw signal data from 19 expression arrays were log base
2-transformed and processed by 75th percentile shift
normalization using the GeneSpring GX software (Agi-
lent Technologies) as described [27–29]. Further, the ro-
bustness of data among the biological replicates for both
untreated (UT) and vit C-treated samples was analyzed
by hierarchical clustering (Fig. 1b). Next, expression fold
change with p-values (student t-test) of all vit C treated
conditions was calculated with respect to their time-
matched untreated (UT) controls. Genes for analysis
were selected by filtration at probe level. If there were
multiple probes for the same gene, and they showed
similar fold expression values (i.e. either all positives or
all negatives), then the gene was selected for analysis,
and where different probes for the same gene showed
opposite fold expression values (positive and negative),
that gene was removed from the analysis. Thus, at every
time-point, ~5000 genes were not considered and ~
25,000 genes were considered for analysis. Significant
expression values were determined based on log2 fold
change ≥ 1 with Benjamini-Hochberg FDR correction
(q ≤0.05). Microarray experiments were performed at
Genotypic Technology (Bengaluru, India) and the results
are deposited at http://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc=GSE73421. The biological significance of the
gene expression modulation on vit C-treatment was ana-
lyzed using an online enrichment tool GOrilla (Gene
Ontology enRIchment anaLysis and visuaLizAtion Tool;
http://cbl-gorilla.cs.technion.ac.il, [30]) using the input
option of a single ranked list of genes on the basis of ex-
pression value. Gene descriptions explained in the results











PMA-differentiated THP-1 cells 
Untreated (UT) Vit C-treated 
RNA Isolated at 8, 24, 48 and 96 hrs 
        (three biological replicates) 
Microarray Analysis 
       (19 datasets) 
Biological replicates with RIN 7  
Data extraction and 75th percentile shift  
normalization for each array 
Fold change calculated for vit C –treated samples  
vs. time matched UT controls  
Experimental Design 
DRGs were filtered based on Log2 fold change 1 (p-value 0.05)  
Genes were selected by filtration at probe level;  
Genes for which multiple probes show  
















































































































Vit C (VC)-treated samples
-2                 0                  2
Fig. 1 Microarray experimental and analysis details. a Flow plan for Experimental design and Microarray analysis, RIN indicates RNA Integrity
number b Hierarchical clustering of log2 transformed 75th percentile normalized values for untreated (UT) samples and vit C-treated samples (VC)
are shown, indicating the replicate confidence
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Intracellular vit C estimation
For vit C estimation, DNPH method was used [31]. The
experimental set up was the same as that for gene ex-
pression analysis and performed in triplicate. Briefly, at
the individual timepoints (8, 24 and 48 h), THP-1 cells
(UT and Vit C-treated) were scraped and harvested at
1200 rpm for 10 min. The pellet from two flasks was
resuspended in 200 μl water and the suspension was
subjected to four consecutive freeze-thaw cycles in
chilled ethanol and 37 °C water bath for one minute
each. Further, the protocol was same as described [31].
Viability of vit C-treated THP-1 cells
Briefly, ~5 × 104 THP-1 cells were seeded in a 96-well
tissue culture plate in triplicate wells and differentiated
with 30 nM PMA for 16-18 h. The cells were washed
and allowed to rest for 2-3 h. This was followed by the
addition of vit C (100 μM) and the viability of treated
and control wells were assessed using MTT at 96 h.
Briefly, 20 μL of MTT (Sigma-Aldrich®) (5 mg/mL) was
added and incubated for 4–5 h at 37 °C. Following incuba-
tion, media was discarded and the formazan crystals were
solubilized by adding 200 μL DMSO and the absorbance
measured at 590 nm.
Results
Intracellular vit C accumulation
Towards understanding the effect of physiological levels
of vit C on macrophage gene expression, the intracellular
accumulation of vit C was estimated in THP-1 cells. It
was determined to be in the range of 20 to 80 μM, show-
ing highest accumulation at 8 h followed by a decline till
48 h (Fig. 2). This low level is considered to be the base-
line intracellular concentration of Vit C in THP-1 cells
under these conditions. Vit C does not exert any toxic
effect on THP-1 cell viability (Additional file 1: Figure S1).
Temporal transcriptome analysis
Microarray RNA expression data was generated at 8, 24,
48 and 96 h from both vit C-treated and control PMA-
differentiated THP-1 cells as described in Methods. Log2
transformed 75th percentile normalized data was ana-
lyzed by hierarchical clustering (Fig. 1b), establishing the
robustness of the data. Further, the analysis of the
expression of ten representative housekeeping genes and
their raw gProcessed signal intensities (background
subtracted) values showed the data to be normally
distributed (Additional file 2: Figure S2a and S2b). Wide-
spread changes in gene expression over time were noted
upon treatment of differentiated THP-1 cells with
physiological levels of vit C (Fig. 3a). The volcano plots
reflect the extent of differential expression (absolute log2
fold change ≥1) and its significance; the red and green
dots highlight the significantly differentially expressed
genes (p-value ≤0.05) whereas the yellow and blue dots
indicate the non-significant differential expression.
Further, differentially regulated genes (DRGs) with ab-
solute log2 fold change ≥1, p-value ≤0.05 with FDR
correction ≤0.05, indicated a temporal reduction in the
number of DRGs; at 8 and 24 h, there were 872 and 517
DRGs, respectively, and the number decreased to 63 at
96 h following vit C treatment (Fig. 3b). The expression of
genes coding for GLUT and SVCT transporters were not
induced in vit C-treated THP-1 cells; rather a modest
down regulation at 8 and 96 h (nearly 2-fold repression)
was noted. It was reasoned that the cells were exposed to
physiological levels of vit C and moreover, they were not
infected; therefore they are not required to accumulate vit
C against the concentration gradient.
Whole data enrichment analysis
Next, individual enrichment analysis was performed for
the entire temporal data set. GOrilla enrichment tool was
used for this analysis, employing the input option of a sin-
gle ranked list of genes on the basis of expression values.
The significantly enriched functional classes (p-value of en-
richment ranging from 10-4 to 10-15 with FDR correction,
q-value ranging from 10-4 to 10-13) were selected for gain-
ing insights into global responses of THP-1 cells to vit C.
Clustering of predominant functional responses
The functional enrichment is depicted as up- and down-
regulated classes (described in sections below) to highlight
the diversity in biological processes in response to vit C.
Further, the representation of the data does not
exclude the possibility that different genes under a
particular GO term respond in different directions.
There are functional classes that showed significant
Fig. 2 Intracellular concentration of vit C. PMA-differentiated THP-1
cells were treated with 100 μM vit C. The intracellular concentration
of vit C was estimated in the control (untreated, UT) as well as vit C-
treated cells. Mean ± SD is plotted from 3 biological replicates values.
P-value was calculated using Two-tailed unpaired t-test (p-value less
than or equal to 0.05 was considered to be significant)
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enrichment under both up and down-regulated cat-
egory thereby signifying the differential regulation of
genes for the same biological process.
The up-regulated functional classes were assigned into
two groups (Fig. 4a): (1) up-regulated at late time-points
i.e. 48 and 96 h (Group I: 8 functional classes), and (2),
Fig. 3 Differentially regulated genes (DRGs) on treatment with vit C. a Volcano plots depicting the magnitude and significance of differential
expression at all time-points. Each dot on the plot is single gene. Vertical lines represent the fold change -1≤ 0≥ 1 and horizontal lines represent
the p-value ≤0.05 b DRGs were determined using the absolute log2 fold change ≥1 (p-value ≤0.05, FDR≤ 0.05)
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up-regulated from 24 h, onwards (Group II: 3 functional
classes). Similarly, the down–regulated functional classes
were categorized into three groups based on their temporal
clustering pattern (Fig. 4b): (1) down-regulated at all the
time-points (Group III: 24 functional classes), (2) common
response at 24, 48 and 96 h (Group IV: 6 functional clas-
ses), and (3) common responses at 8, 24 and 48 h (Group
V: 9 functional classes). In addition to these common re-
sponses, several functional classes were enriched uniquely
at a specific time-point (discussed in a later section).
Up-regulated cluster of functional classes
The functional classes in Groups I and II (Fig. 4a) are
highly relevant in the context of macrophage func-
tion, especially in relation to infection. The GO class
‘Chronic inflammatory response’ reflected the role of
vit C in immune function, and included 4 genes,
VNN1, PTGES, S100A8 and S100A9, emphasizing
their role in oxidative stress response, signaling path-
ways and in regulation of cytoskeleton (Fig. 5a). A
second noteworthy up-regulated GO class is ‘Extracellular
matrix (ECM) organization’ and included the genes
MMP2, COL16A1, MFAP5, LUM, ADAMTS2 and
MYH11, that play important roles in inflammation and in
remodeling and maintaining the integrity of ECM (Fig. 5a).
The third relevant class in Group I is ‘Positive regulation
of sequence-specific DNA-binding transcription factor
activity’, which included NEUROG1, that codes for a tran-
scriptional regulatory protein (Fig. 5a). Further, the GO
classes that showed sustained up regulation from 24 h
onwards were classified into group II and included ‘In-
flammatory response’ (8 genes), ‘Response to wounding’
(11 genes) and ‘Chemokine production’ (3 genes, Fig. 5b).
The up regulation of these classes suggested a role for vit
C in preparing macrophages for their role as the first line
of defence.
Down-regulated cluster of functional classes
Similarly, the classes that were down-regulated in re-
sponse to vit C were classified into 3 groups (Fig. 4b).
Time (hrs) 
6984428)50.0q,detcerrocRDF(ssalClanoitcnuFOG
Chronic inflammatory response 1 1
Cellular component movement 1 1
Response to external stimulus 1 1
Extracellular matrix organization 1 1
Locomotion 1 1
Extracellular structure organization 1 1
Cell motility 1 1
Positive regulation of sequence-specific DNA binding transcription factor activity 1 1
Inflammatory response 1 1 1
Response to wounding 1 1 1
Chemokine production 1 1 1
Group I
Group II
8 24 48 96
System process 1 1 1 1
Signal transduction 1 1 1 1
Cell surface receptor signaling pathway 1 1 1 1
Anatomical structure morphogenesis 1 1 1 1
1111sisenegohpromnagrO
Regulation of cell communication 1 1 1 1
Regulation of signaling 1 1 1 1
Cell differentiation 1 1 1 1
1111ssecorplamsinagroralullecitluM
1111ssecorplatnempoleveD
Response to lipid 1 1 1 1
Regulation of cell proliferation 1 1 1 1
Single-multicellular organism process 1 1 1 1




Anatomical structure development 1 1 1 1
1111ssecorplatnempolevedralulleC
Regulation of developmental process 1 1 1 1
1111sulumitsotesnopseR
Positive regulation of developmental process 1 1 1 1
Regulation of multicellular organismal process 1 1 1 1
Regulation of multicellular organismal development 1 1 1 1
Cell adhesion 1 1 1
Biological adhesion 1 1 1
Chemical homeostasis 1 1 1
Ion homeostasis 1 1 1
111ssecorpmetsyslacigolorueN
111sisatsoemohlacimehcralulleC
Regulation of signal transduction 1 1
Regulation of anatomical structure morphogenesis 1 1
11noitaitnereffidnorueN
11ssecorpmsinagro-elgniS
Regulation of cell differentiation 1 1
Negative regulation of cell differentiation 1 1
Positive regulation of cell differentiation 1 1
Negative regulation of developmental process 1 1





(A) (B) GO Functional Class (FDR corrected, q 0.05)
Fig. 4 Clustering of enriched functional gene classes. Whole data enrichment analysis was performed using GOrilla, where the genes were ranked
for up and down regulation. Enriched classes (filtered using p-value of enrichment <0.001, FDR corrected q ≤ 0.05) showing common temporal
occurrence were grouped. a Up-regulated (red) GO classes classified into two groups, b Down-regulated (green) GO classes classified into three
groups (solid black boxes)
Batra et al. BMC Genomics  (2017) 18:252 Page 6 of 16
Group III constitutes a large number of GO classes that
were persistently down-regulated at all the four time-
points. Many of these classes were from the top-level
hierarchy (‘System process’, ‘Anatomical structure mor-
phogenesis’ etc.) and therefore, highlight a more broad
function and are not discussed in detail. The classes
relevant to the scope of the present study are discussed
below and included ‘Signal transduction’, ‘Cell surface re-
ceptor signaling pathway’ and ‘Regulation of signaling’,
reflecting the significant extent of modulation at tran-
scriptional level exerted by vit C. The genes among the
classes included FFAR3, ZP4, ENAH, AMELX, RNF43
and GPR18 (Fig. 6a) involved in energy homeostasis,
cytoskeleton remodeling and important in the regulation
of immune system. The group IV cluster includes enriched
functional classes down-regulated from 24 h onwards
(Figs. 4b and 6b), namely, ‘Cell adhesion’, ‘Biological adhe-
sion’, ‘Chemical homeostasis’, ‘Ion homeostasis’ and ‘Cellular
chemical homeostasis’. These GO classes are structured at
different levels of hierarchy and mainly fall into ‘Cell adhe-
sion’ and ‘Chemical homeostasis’ at the top level of hier-
archy. The down regulation of genes in ‘Cell adhesion’ class
(such as AMIGO1, CCL5, CNTN1, NEDD9 and NTM
genes) suggested the role of vit C in regulating signaling
complexes important in cell attachment, migration and
invasion as well as apoptosis and cell cycle. The class
‘Chemical homeostasis’ belongs to a higher level of hier-
archy and covers ‘Ion homeostasis’ and ‘Cellular chemical
homeostasis’ (Fig. 4b). Group V i.e. functional response
common from 8 to 48 h, is mainly represented by the class
‘Regulation of signal transduction’ (Fig. 6c). As mentioned
above and explained in later sections also, although the
classes have an overlap, they clustered differently based on
the temporal expression of discrete genes in each class. In
summary, the common responses to vit C, both up and
down-regulated, shed light on adaptation mechanisms
employed by macrophages to prepare themselves for their
defensive function. Vit C also seems to exert a regulatory
role in maintaining homeostasis by regulating diverse
activities such as inflammation, adhesion, signaling and
ECM remodeling.
Unique temporal responses
In addition to the common transcriptional response
described above, several functional classes showed
time-dependent expression following vit C treatment.
The classes pertinent to the role of THP-1 cells in
macrophage function are discussed in detail.
Early response to vit C (at 8 h)
One of the relevant classes enriched at the earliest time-
point studied was ‘Regulation of gene expression’. This
enriched class includes a large number of genes coding
for zinc finger proteins that act as transcriptional regula-
tors as well as other regulatory genes such as ASCL1
and POU3F3. Few other classes that were functionally
Gene Symbol 8 24 48 96
VNN1 0 0 1.9 0.8
PTGES 0.4 -0.1 1.9 0.8
S100A8 -0.1 1.2 1.6 1.1
S100A9 0.6 1.1 1.4 1.6
VCAN 0.4 0.4 1.2 1.7
LAMB1 -0.9 -0 1.3 2.1
S100A12 -0 1 1.5 1.6
KIF25 1.1 2 3.1 2
WNT5A 0.2 0.8 1.2 1.4
POU3F3 1.6 1.2 1.4 1.4
ASCL1 1.5 0.8 1.2 1
PTGS2 -0.8 1.1 2.1 1.4
S100P -0.1 0.7 3.6 0.9
CTHRC1 0.5 1.4 2 0.9
SCG2 0 0.8 2.3 1.9
VEGFA 0 0.7 1.6 0.8
SLC7A11 0 0 1.7 1.2
CDC42BPA 0 0 2 2
CD48 -1.2 0 1.4 2
CACNA1E 2.1 0.6 2.3 0.9
SEMA3F 0 -0.6 1.4 1.3
GREM1 1.1 0.4 1.4 1
FAT2 1.8 0.8 1.5 1.3
VNN1 0 0 1.9 0.8
S100A8 -0.1 1.2 1.6 1.1
S100A9 0.6 1.1 1.4 1.6
MMP2 0 -0.5 1.2 1.4
COL16A1 0.4 0.4 2.3 1.7
MFAP5 0.4 1.9 4.1 1.3
LUM 0.4 -0.6 3.4 4.5
ADAMTS2 0 0 1 1.2
MYH11 -1.8 1.1 1.5 1.8






Positive regulation of sequence specific 
DNA binding transcription factor activity
Gene Symbol 8 24 48 96
STAB1 0 1.3 1.1 3.1
CXCL1 0.3 0.9 1.3 1.4
S100A12 -0 1 1.5 1.6
PTGS2 -0.8 1.1 2.1 1.4
SCG2 0 0.8 2.3 1.9
S100A8 -0.1 1.2 1.6 1.1
S100A9 0.6 1.1 1.4 1.6
CCL13 0.4 1.2 1.1 1.4
EREG -0.1 1.4 1.7 1.2
STAB1 0 1.3 1.1 3.1
CXCL1 0.3 0.9 1.3 1.4
DCN 0.3 0.6 2.3 2.8
S100A12 -0 1 1.5 1.6
PDGFRB -0.2 1.8 1 1.2
WNT5A 0.2 0.8 1.2 1.4
PTGS2 -0.8 1.1 2.1 1.4
SCG2 0 0.8 2.3 1.9
S100A9 0.6 1.1 1.4 1.6
CCL13 0.4 1.2 1.1 1.4
NOD2 0.1 1 1.8 1.5
S100A8 -0.1 1.2 1.6 1.1






-1               0                1
(A) (B)
Fig. 5 Gene expression profile of the up-regulated group of GO classes. Log2 fold expression values are shown of the genes falling under the mentioned
GO classes that were commonly present (a) at 48 h and 96 h (Group I), (b) from 24 h onwards (Group II). Genes shown here are not filtered according to
FDR corrected p-value, since these represent common occurrence. FDR corrected p-values for the genes ranged from 0.03 to 0.09
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linked to the ‘Regulation of gene expression’ were also
enriched i.e. ‘Transcription DNA-dependent’, ‘mRNA
transcription from RNA pol II promoter’ and ‘Regulation
of RNA biosynthetic process’. All of these classes were
analyzed for the temporal expression values of the re-
spective genes and many of the genes were commonly
present in these classes. The temporal expression be-
havior of these genes showed upregulation at 8 h (Log2
fold ≥1, p-value ≤0.05 and q ≤0.05) (Fig. 7a) and subse-
quent decrease in expression. This indicated that vit C
induces early extensive gene expression changes at the
transcriptional level, suggesting its role in preparing
cells for a future event, such as an infection. The ex-
pression of target genes for some of the up-regulated
transcriptional regulators (derived from the database
HTRIdb, http://www.lbbc.ibb.unesp.br/htri) was low-
ered at later time points. For example: the down-
regulated target genes of ASCL1 i.e. DKK1, IGF2 and
PCSK6, are involved in ‘Regulation of gene expression’
and ‘Regulation of Signal transduction’ thereby suggest-
ing the early effect of vit C on transcription, hence
modulating the expression of many target genes falling
into diverse biological processes at later time points till
96 h. A brief analysis of the induced transcriptional
regulators and their target gene expression is shown in
Additional file 3: Table S1.
The enrichment result for the down-regulated classes
revealed that the majority of the classes were not obvi-
ously linked to the function of macrophages under ex
vivo condition. An exceptional class ‘Positive regulation
of MAPK cascade’ (Fig 7b) is discussed, as it is under
‘Regulation of signal transduction’ class, which seemed
to be a continuous response to vit C (Fig. 4b). The func-
tion of these genes (Fig. 7b) covers a wide spectrum of
functional processes such as growth and differenti-
ation, cell survival and macrophage function, some
genes play an essential role in innate immune re-
sponse and inflammation and are involved in cytoskel-
eton reorganization.
Response at 24 h
Three major biological processes predominate the func-
tional response to vit C at 24 h. The enriched GO classes
broadly fall into ‘Cell cycle’, ‘Chromosome organization’
and ‘DNA metabolic process’ at a higher level of hierarchy
(Table 1). Out of 87 GO classes enriched at 24 h, 17
classes (p ≤ 0.001 and q ≤0.05) belong to ‘Cell cycle’, 11
classes (p ≤ 0.001 and q ≤0.05) belong to ‘Chromosome
organization’ and 18 classes (p ≤ 0.001 and q ≤0.05) belong
to ‘DNA metabolic process’ (Table 1). Using the 2-fold
criterion and corrected p-value ≤0.05, the class ‘Cell cycle
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Fig. 6 Gene expression profile of the down-regulated group of GO classes. Log2 fold expression values are shown of the genes falling under the
mentioned GO classes that were (a) commonly present from 8 h to 96 h (Group III), (b) commonly present from 24 h onwards (Group IV), and (c)
commonly present from 8 h to 48 h (Group V). Genes shown here are not filtered according to FDR corrected p-value, since these represent
common occurrence. FDR corrected p-values for the genes ranged from 0.03 to 0.09
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and MCM10. Similarly, another class in Cell cycle cat-
egory is ‘Cell cycle phase transition’ and included genes
CDC7, MCM10. Some of the genes directly play a role at
the mitotic spindle (LRRCC1), others regulate at the level
of DNA replication (CDC7, BLM, MCM10). The enrich-
ment of as many as 17 GO classes belonging to the ‘Cell
cycle’ and ‘Biological phase’ at higher hierarchy indicate
the significant regulatory role of vit C in cell cycle. The
second category ‘Chromosome organization’ included 11
GO classes (Table 1). The first in the list, ‘ATP dependent
chromatin remodeling’, contains genes i.e. MLF1IP and
CENPK. These genes play an important role in centro-
mere assembly (MLF1IP) along with CENPK. The third
major representative class was ‘DNA metabolic process’,
which included a total of 18 classes, such as ‘DNA repair’,
‘DNA recombination’ and ‘DNA replication’ (Table 1). In
conclusion, the response of THP-1 cells at 24 h was pre-
dominantly linked to cell cycle regulation via regulating
events at phases of cell cycle, chromosome remodel-
ing and DNA metabolism. Importantly, the func-
tional cellular responses associated with signaling
appear to be under the regulation of vit C. The classes
‘Positive regulation of signal transduction’ and ‘Negative
regulation of signal transduction’ both showed enrich-
ment; in fact this regulatory role of vit C was observed
from 8 h onwards.
Responses at 48 h
Proceeding to later time-points, the identity of the most
represented classes provided clues to the immune-
modulatory role of vit C. The prominent functional clas-
ses included ‘Activation of immune response’, ‘Positive
regulation of immune response’, ‘Positive regulation of
inflammatory response’ and ‘Cell communication’. There
is an extensive gene overlap among the classes ‘Positive
regulation of immune response’ and ‘Activation of im-
mune response’, therefore; only one class is mentioned
(Fig. 8a). The enrichment of these classes suggests that
vit C likely plays an indispensable role in macrophages
function in innate defence e.g. up regulation of genes
coding for innate receptors (NOD2, TLR3, MARCO,
COLEC12), and associated proteins that co-operate with
TLR in response to bacterial LPS (LY96). In the same
way, the genes involved in immune response i.e. part of
inflammasome (NLRC4) and signaling protein (PIK3CD)
indicated the fundamental role of vit C in the immune
system. Interestingly, CREB1 was up-regulated at 48 h;
CREB has been shown to induce the transcription of
immune-related genes that possess a CRE element and
hence, one of the ways in which vit C exerts its immune
modulatory effect is via CREB. The enriched classes that
showed down regulation at 48 h were ‘Regulation of cAMP
metabolic process’, ‘Cholesterol transport’, ‘Cellular metal
ion homeostasis’ and ‘Extracellular matrix organization’
(Fig. 8a). In view of the earlier described enriched class
‘Regulation of gene expression’, the enrichment of the GO
class ‘Regulation of cAMP metabolic process’ was consid-
ered relevant. The down-regulated genes included those
associated with the activation of adenylate cyclases (e.g.
ADRB2, GNG7, VIPR2) and with the inhibition of adenyl-
ate cyclase, GABBR2 (Fig. 8a). This is suggestive of the
regulatory effect of vit C on adenylate cyclase activity,
thereby possibly modulating the levels of cAMP. The down
regulation of genes under the class ‘Cholesterol transport’
(APOC2, LIPG, MSR1, NPC2, OSBPL5, SOAT2) suggested
the modulation in the uptake (MSR1), lipase activity
(LIPG) and egress (NPC2) of cholesterol on vit C treat-
ment. This emphasized the importance of vit C in main-
taining cholesterol balance. One interesting finding was the
enrichment of class ‘Extracellular matrix organization’. The
role of vit C in ECM remodeling has already been dis-
cussed under common up-regulated group of genes
(Fig. 5a), and here the class was enriched under down
regulation. This suggested that different choices are
exerted in terms of genes regulation, depending upon the
requirement of the cell e.g. at 48 h COL16A1 was up-
regulated and COL8A1 was down-regulated (Fig. 8a). Also,
(A) (B)
-1               0                1
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Gene Symbol 8 24 48 96
BMP4 -1.4 -1.6 -2.3 -1.2
GPR55 -1.3 0.0 -0.4 0.0
KISS1 -1.2 -0.6 0.1 0.0
LIF* -1.7 -0.9 -1.0 0.0
OSM* -1.4 -1.4 -0.4 -1.6
WNT7A -1.4 -0.4 -0.7 -1.4
Gene Symbol 8 24 48 96
ASCL1* 1.5 0.8 1.2 1.0
ASCL*5 1.6 0.7 1.3 0.5
BRD*3 2.3 -0.9 2.4 0.0
CLK3* 1.8 0.0 0.0 -0.6
EVX1 1.9 0.4 1.8 0.8
FOXB1* 3.1 2.0 2.1 0.4
GRIN1 2.1 0.0 1.5 0.0
LGR4 1.6 0.3 0.0 0.0
MAGEA1* 3.2 1.7 2.5 2.9
NEUROG1 3.4 1.7 3.5 2.1
PIAS4* 4.3 0.0 0.0 -0.1
POU3F3* 1.6 1.2 1.4 1.4
SOX17* 3.0 0.0 1.9 0.0
SOX18* 2.3 0.7 1.5 0.6
TAGLN3* 1.8 -0.4 1.6 0.0
UCN2* 2.2 1.4 2.2 1.1
UTF1* 1.5 0.6 1.0 -1.0
ZNF154* 1.7 0.8 0.0 0.0
ZNF205* 2.1 1.0 1.6 1.1
ZNF43* 2.3 0.2 2.1 0.8
ZNF493* 1.9 0.8 0.0 0.0
ZNF516* 1.6 0.0 2.8 0.8
ZNF626* 2.2 0.8 0.2 1.1
ZNF676 1.5 1.1 1.6 0.1
ZNF678* 1.8 0.0 0.0 1.4
ZNF784* 1.5 0.9 1.8 1.1
ZNF844* 1.9 2.4 2.2 0.1
ZNF878 1.6 0.6 0.4 0.6
ZSCAN10 1.5 0.3 1.5 0.9
Time (hrs)
Fig. 7 Gene expression profile of the enriched GO classes at 8 h
post vit C treatment. a ‘Regulation of Gene expression’ b ‘Positive
regulation of MAPK cascade’. The values of the genes represent the
log2 fold change ≥1 (p-value ≤0.05), asterisk marked genes have
FDR q ≤0.05. Up-regulated and down-regulated classes are indicated
in red and green, respectively
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Table 1 Predominant enriched GO classes at 24 h in vit C-treated THP-1 cells
GO Term Description Higher hierarchya P-value* FDR q-valueb
GO:0007049 Cell cycle Cell cycle 3.41E-09 0.000
GO:0000075 Cell cycle checkpoint Cell cycle 1.76E-06 0.001
GO:0022403 Cell cycle phase Biological phase 8.15E-13 0.000
GO:0044770 Cell cycle phase transition Cell cycle 2.75E-06 0.001
GO:0022402 Cell cycle process Cell cycle 6.52E-15 0.000
GO:0031570 DNA integrity checkpoint Cell cycle 1.33E-05 0.004
GO:0000082 G1/S transition of mitotic cell cycle Cell cycle 8.40E-05 0.019
GO:0000279 M phase Biological phase 2.25E-04 0.043
GO:0000087 M phase of mitotic cell cycle Cell cycle 1.89E-04 0.039
GO:0007126 Meiosis Cell cycle 3.44E-06 0.001
GO:0007067 Mitosis Cell cycle 2.06E-04 0.041
GO:0000278 Mitotic cell cycle Cell cycle 7.08E-13 0.000
GO:0044772 Mitotic cell cycle phase transition Cell cycle 2.75E-06 0.001
GO:0000083 Regulation of transcription involved in G1/S phase of mitotic cell cycle Cell cycle 1.34E-06 0.001
GO:0051320 S phase Biological phase 6.16E-06 0.002
GO:0000084 S phase of mitotic cell cycle Cell cycle 1.62E-05 0.005
GO:0032201 Telomere maintenance via semi-conservative replication Cell cycle 5.83E-07 0.000
GO:0043044 ATP-dependent chromatin remodeling Chromosome organization 5.29E-06 0.002
GO:0034080 CENP-A containing nucleosome assembly at centromere Chromosome organization 3.34E-07 0.000
GO:0006333 Chromatin assembly or disassembly Chromosome organization 7.41E-06 0.003
GO:0031055 Chromatin remodeling at centromere Chromosome organization 4.74E-07 0.000
GO:0006336 DNA replication-independent nucleosome assembly Chromosome organization 3.34E-07 0.000
GO:0034724 DNA replication-independent nucleosome organization Chromosome organization 3.34E-07 0.000
GO:0043486 Histone exchange Chromosome organization 3.12E-06 0.001
GO:0006334 Nucleosome assembly Chromosome organization 2.18E-06 0.001
GO:0034728 Nucleosome organization Chromosome organization 3.98E-05 0.011
GO:0010833 Telomere maintenance via telomere lengthening Chromosome organization 5.60E-05 0.014
GO:0032200 Telomere organization Chromosome organization 5.83E-05 0.014
GO:0006259 DNA metabolic process DNA metabolic process 2.44E-10 0.000
GO:0006310 DNA recombination DNA metabolic process 6.21E-07 0.000
GO:0006281 DNA repair DNA metabolic process 1.15E-08 0.000
GO:0006260 DNA replication DNA metabolic process 4.57E-14 0.000
GO:0006270 DNA replication initiation DNA metabolic process 5.44E-07 0.000
GO:0022616 DNA strand elongation DNA metabolic process 1.47E-14 0.000
GO:0006271 DNA strand elongation involved in DNA replication DNA metabolic process 3.82E-15 0.000
GO:0006268 DNA unwinding involved in replication DNA metabolic process 2.23E-04 0.044
GO:0006261 DNA-dependent DNA replication DNA metabolic process 2.36E-05 0.007
GO:0000724 Double-strand break repair via homologous recombination DNA metabolic process 8.53E-06 0.003
GO:0045005 Maintenance of fidelity involved in DNA-dependent DNA replication DNA metabolic process 9.31E-05 0.020
GO:0006312 Mitotic recombination DNA metabolic process 7.17E-06 0.003
GO:0006297 Nucleotide-excision repair, DNA gap filling DNA metabolic process 3.51E-05 0.010
GO:0000725 Recombinational repair DNA metabolic process 1.28E-05 0.004
GO:0051052 Regulation of DNA metabolic process DNA metabolic process 1.02E-05 0.003
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at 48 h the selection of MMPs were different (Fig. 5a
and Fig. 8a). The enrichment of the class ‘Cellular
metal ion homeostasis’ emphasizes the important role
of vit C in maintaining ion equilibrium inside the
macrophages. This class included genes coding for re-
ceptors (F2R) and ion channels (KCNK3). In addition,
the gene involved in the maintenance of iron homeostasis
and for the regulation of iron storage in macrophages, was
also down-regulated on vit C treatment (HAMP, Fig. 8a).
As seen from the analysis, vit C treatment affected func-
tional responses related to the maintenance of homeosta-
sis, which is not surprising. Rather, the novelty lies in the
gamut of regulatory roles played by vit C, at least at the
transcriptional level.
Responses at 96 h
Persisting from 48 h onwards were the ‘Immune system
process’ and ‘Regulation of cytokine secretion’ classes
that reflect vit C to be of paramount importance for
immune system function (Fig. 8b). Consistent with this
role, the up-regulated classes at 96 h include genes
coding for chemokines, coding for molecules involved in
antigen presentation (Fig. 8b). Thus, vit C exerts its
regulatory role on immune recognition (CD1 and HLA)
as well as on levels of cytokines/chemokines, thereby aid-
ing macrophages’ role in innate defence. Importantly, the
expression pattern at the later time-point of the study i.e.
96 h, is indicative of a sustained cellular response to vit C.
Among the down-regulated classes, the enrichment of
the class ‘Adenylate cyclase modulating GPCR signaling
pathway’ indicated a sustained modulatory effect of vit C
on cAMP levels and associated signaling (Fig. 8b). A
careful examination of the genes involved, revealed the
down regulation of genes responsible for the activation
of adenylate cyclase (e.g. ADRB2, CALCRL) and also, the
inhibition of adenylate cyclase activity (e.g. CHRM2,
OPRK1, NPY1R). The plausible underlying explanation
could be that it is the balance in the activities of these
opposing functions, depending on the stimuli and their
duration, which ultimately determines the intracellular
levels of cAMP. Linked to the class ‘Chemical ion homeo-
stasis’ described at 48 h, the down regulation of ‘Calcium
related signaling using intracellular calcium source’ indi-
cated the modulation of calcium ion-associated signaling
pathways on vit C-treatment. The decreased expression of
HOMER2 (interacts with Ryanodine receptors (RYR)) and
also of the GPCR i.e. GPR143 that stimulates Ca2+ influx
into the cytoplasm suggested modulatory effect of vit C
on calcium-associated signaling (Fig. 8b).
It is imperative to emphasize that although the temporal
response to vit C was analyzed in a step-wise manner, the
functional responses clearly reflected an interconnection
of the biological pathways, that are integrated in a whole
biological system.
Discussion
The biological role of dietary antioxidant molecules is
no longer simply ascribed to their ability to serve as
‘electron donors’; rather, antioxidants such as vit C in
the present context, also act by modulating gene expres-
sion and signaling. In vivo and in vitro studies have
shown that some of the effects of vit C on cells are at
the transcriptional level [32–34]. The present study is
the first report of the genome-wide effects of vitamin C
on gene expression of differentiated THP-1 cells treated
with a physiologically relevant concentration of vit C,
namely circulating plasma concentration of ~ 100 μM.
The intracellular concentration of vit C in THP-1 cells
ranged between 20 μM and 80 μM during 8 to 48 h.
Macrophages are expected to be constantly exposed
to ~ 70 to 100 μM levels of vit C in nutritionally ad-
equate subjects [5], therefore, the observed modula-
tion of gene expression can be considered as a baseline
macrophage-like cell response to physiological concentra-
tions of vit C. It is remarkable that this baseline concen-
tration of vit C mediates widespread changes in gene
expression of THP-1 cells as revealed by whole genome
enrichment analysis.
The major physiological processes modulated on vit C
treatment in THP-1 cells are represented in Fig. 9. The
earliest response (8 h) to vit C was reflected in the
enriched ‘Regulation of gene expression’ GO class. The
majority of the genes included in this class are transcrip-
tional regulators. The target genes of some of these reg-
ulators (Fig. 7, Additional file 3: Table S1) function in
diverse processes such as ECM organization and signal
transduction. This was consistent with the recognized
role of vit C in increasing collagen gene transcription in
various cell types such as chondrocytes and skin fibro-
blasts, [35–39], stabilizing collagen mRNAs [40] and
increasing procollagen secretion [41]. This suggests that
ascorbate action not only involves hydroxylation and
Table 1 Predominant enriched GO classes at 24 h in vit C-treated THP-1 cells (Continued)
GO:0006275 Regulation of DNA replication DNA metabolic process 7.56E-05 0.018
GO:0000723 Telomere maintenance DNA metabolic process 4.14E-05 0.011
GO:0000722 Telomere maintenance via recombination DNA metabolic process 2.71E-06 0.001
*p-value, significance value of Gene ontology enrichment (determined in GOrilla analysis)
aEach enriched GO term at 24 h is listed with the higher hierarchy GO term as determined from the Amigo 2 tree view (amigo.geneontology.org/amigo)
bFDR q-value, p-values after multiple testing correction
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stabilization of the collagen triple helix [42], it also
involves direct or indirect effects on gene expression
and protein secretion. ‘Regulation of cAMP metabolic
process’ was detected as an enriched class from 48 h
onwards, which pointed towards the modulatory effects
of vit C on cAMP, consistent with vit C being proposed
as a ‘global regulator’ of intracellular cAMP [43, 44].
This advances the possibility that the modulatory effects
of vit C on cAMP might be one of the mechanisms by
which vit C regulates gene expression.
Vit C seemed to exert its effect on other notable func-
tional processes in THP-1 cells as well, namely, ‘Cell
cycle’, ‘DNA replication’ and ‘Chromosomal organization’
(Table 1) at 24 h and included genes belonging to vari-
ous GO classes reflecting role of vit C at different steps
in the cell cycle such as cell cycle check point, G1 to S
transition, genes involved in DNA replication and repair
as well as genes involved in chromosomal remodeling.
Many reports have explained the effect of vit C on cell
cycle processes [45, 46]. Similarly, Belin et al. demon-
strated the anti-proliferative role of vit C, potentially due
to the inhibition of expression of genes involved in cell
division progression [47]. Another noteworthy response
to vit C was ‘Extracellular matrix organization’ biological
process. ECM organization is a well-known process
where vit C plays an essential role. This class was
enriched in both up and down regulation (summarized
in Fig. 9) and is consistent with the essential cofactor
function of vit C in the synthesis of collagen, the main
structural component of ECM. Vit C is required for the
hydroxylation of proline residues in collagen chains by
prolyl hydroxylase [48], for proper triple helix assembly
Enriched classes at 48 hrs
Activation of Immune Response
Cell communiation
Positive regualtion of Inflammatory response
NOD2*, TLR3, MARCO*, CREB1, LY96, VSIG4*, MICB*, C2*, CD3D*, 
NLRC4, PIK3CD*, COLEC12
Enriched classes at 48 hrs
Regulation of cAMP metabolic process
Cholesterol transport
Cellular metal ion homeostasis
Extracellular matrix organization
ADM*, ADRB2, EDN1*, GABBR2, GNG7, VIPR2
APOC2*, LIPG*, MSR1*, NPC2*, OSBPL5*, SOAT2
Enriched classes at 96 hrs
Immune system process
Regulation of cytokine secretion
TLR3, CCR7*, PTGS2*, ZP3, S100A8, WNT5A*, IL23A, 
S100A9*, S100A12, CCL24
IL11*, GRM1, DRD5, GDNF*, STC2, FOXB1, ASNS, NPBWR1, 
ALDH2*, PLAT*, GJB2*, KCNA10, EREG*, CREB1, HCRTR1*, 
FNIP1, S100A9*, KCNJ15, CCL23, LILRB2, GRIN2D, CCL24, 
WNT5A, TITF1*, KCNK7, CXCL5*, TH, STAB1*, SYN1, SNX22, 
GNB3, HTR1E
COLEC12, CXCL5, CLEC4D, IL1R2, CXCL6, CLEC5A, RPS6KA5, 
CD48, CD1C, PIK3R3, SCG2*, CXCL14, AMICA1, NCR1, CD86, IL11, 
HAMP*, ENPP2, HLA-DMB, GPAM, CCL13, PTPRC, HLA-DRB5,  
TRIM22, VSIG4, CD93, CTSK, CD1A, DICER1, CD1E
IL33, C1QTNF3, CLEC5A, GPAM, HLA-DRB5
Enriched classes at 96 hrs
Adenylate cyclase modulating GPCR signaling pathway
Calcium-mediated signaling using intracellular 
calcium source
CHRM2, NPY1R, ADRB2, ADRA1B, ADCY5, OPRK1, GNAT1,
CALCRL, PTHLH, NPY2R,  GRIK3
GPR143, HOMER2, ODZ2
F2R, KCNK3, ATP6V1C2, ADM, CXCL13, HAMP, CCL5, EDN1, GHRL, 
CX3CR1




Fig. 8 Sustained functional responses of THP-1 to vit C-treatment. Functional classes enriched at (a) 48 h and (b) 96 h are shown. The genes
mentioned for each class, induced (red) or repressed (green), were obtained using log2 fold change ≥1 (p-value ≤0.05), genes marked with
asterisk have FDR q ≤0.05
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in the endoplasmic reticulum and for the secretion of pro-
collagen [49]. A study of skin fibroblasts reported the
modulatory effects of a stable vit C derivative (AA2P) on
ECM remodeling [50]. A comparison of the gene profiles
of THP-1 and skin fibroblast cells revealed a similar GO
enrichment analysis with a differential selection of genes
in these two cell types for the same physiological response.
For example, IL-6 is down-regulated in THP-1 cells,
whereas this gene is induced in skin fibroblasts [50].
‘Modulation of Immune response’ is one of the most
noteworthy functions of vit C (48 h onwards) [51–55].
Vit C appears to mediate the regulation of various
aspects of the immune response, namely, innate recep-
tors, chemokines, antigen presentation, immune signal-
ing and transcriptional regulation. Another interesting
class where vit C exerted its effect was ‘Cholesterol
transport’. The association between cholesterol metabol-
ism and vit C was observed when chronic latent vitamin
C deficiency led to hypercholesterolaemia and choles-
terol accumulation in certain tissues [56], suggesting that
deficiency of vitamin C might deregulate cholesterol
homeostasis. The THP-1 cell infection model is widely
considered as a suitable model for studies of Mtb infec-
tion [21, 23]. Interestingly, Mtb infection results in the
acquisition of a foam cell phenotype [57], wherein, Mtb
maintains itself within lipid bodies and develops drug
tolerance [57, 58]. THP-1 cells have also been estab-
lished as a model to study atherosclerosis due to its
foam cell phenotype [59]. Enrichment analysis in the
present study showed down regulation of genes (Fig. 8a)
participating in lipase activity (ApoC2, LIPG), uptake
(MSR1) and egress (NPC2). Further analysis of ATP-
binding cassette transporters, ABCA1 and ABCG1,
which play a pivotal role in cholesterol efflux from
macrophage foam cells [60], revealed no significant
change in expression. Additionally, nuclear receptors,
peroxisome proliferator activated receptors (PPARs)
known to exert anti-atherogenic effects by enhancing chol-
esterol efflux via activation of the liver X receptor (LXR)-
ABCA1 pathway [61, 62], showed up regulation by nearly
2-fold at 48 h (PPARα and PPARγ). At physiological levels,
the function of vit C in THP-1 cells appears to be more
towards balancing the uptake and efflux of cholesterol and
thereby preventing the formation of foam cells.
A novel role of vit C was observed to be in ‘Cellular
metal ion homeostasis’, particularly in calcium homeo-
stasis as evident by the enrichment of the class ‘Cal-
cium-mediated signaling using intracellular calcium
Fig. 9 Vit C regulates a wide spectrum of biological processes. The enriched functional processes that are up-regulated (red) and down-regulated
(green) along with the top induced or repressed genes (log2 fold change ≥1, with FDR corrected p-value ≤0.05) in the same color code are
shown. Double colored arrow indicates the enriched class under both up- and down-regulation
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source’ (at 96 h). The decreased expression of genes in-
volved in calcium associated signaling such as GPR143
and HOMER2, indicated the regulation of calcium ion
on vit C treatment. There is no report in the literature
to the best of our knowledge that has described this
regulatory role of vit C. Another ion of interest is iron.
Vit C within mammalian systems can regulate cellular
iron uptake and metabolism, both at the transcriptional
and post-transcriptional levels. The major regulatory
factor for the transcriptional control of certain genes
involved in iron metabolism is the HIF system that re-
sponds to changes in oxygen (O2) tension, intracellular
iron and vit C levels. The HIF system includes the O2and
iron-regulated proteins, HIF1α and HIF2α [63, 64]. Under
conditions of normoxia, high levels of vit C (>100 μM)
and iron, prolylhydroxylases are fully active and hydroxyl-
ate the 1α subunit at specific proline residues [65, 66],
targeting HIF1α for proteasomal degradation [67, 68].
Under the condition of low O2 (3–5% O2, in vivo), low
iron, and low vit C, HIF1α /2α proteins are stabilized and
activate the transcription of specific genes that contain
hypoxia- response elements (HREs), such as genes en-
coding Tf(TF), TfR1 (TFRC). Interestingly, none of the
HIF target genes (described by Lane and Richardson
[69]) showed any change of expression in THP-1 cells
on vit C-treatment, possibly owing to the differences in
regulatory mechanism under cell culture and in vivo
conditions [68, 70, 71].
A comparison with the responses of skin fibroblasts to
[50] suggested that macrophages were far more responsive
to treatment with vit C; nearly 294 genes were shown to
be differentially regulated in skin fibroblasts at 5 days [50],
in contrast, 874 genes were differentially regulated at the
earliest time-point i.e. 8 h in THP-1 cells. The number of
DRGs, however, decline from 8 to 96 h.
The absence of cellular response to oxidative stress
was a notable finding of this study. It has been reported
that pharmacological levels of vit C (0.3 mM to 20 mM)
mediate Fenton chemistry that occurs readily in vitro
and generates reactive oxygen species [72]. However,
due to the non-availability of catalytic metal ions in vivo
and in cell culture owing to their sequestration by vari-
ous metal binding proteins such as ferritin, transferrin,
and ceruloplasmin [73, 74], there are minimal chances
of the occurrence of Fenton reaction [74]. Thus, the
pro-oxidant effect of vit C can be ruled out in the
present study as vit C was used at physiological levels
and not at pharmacological levels [72, 75].
Conclusions
In conclusion, this genome-wide transcriptome analysis
has disclosed that vit C, being an essential dietary compo-
nent, regulates a wide spectrum of biological processes in
THP-1 macrophages. These insights have opened a new
dimension to be explored towards understanding the
pleiotropic effects of vit C on eukaryotic gene expression
and function. The study will also have an impact on curat-
ing databases and biological networks. The present find-
ings further point towards the potential utility of the
THP-1 cell model for examining the role of vit C in
modulating macrophage responses to various stresses,
including infection by intracellular pathogens.
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